Is Autolus Therapeutics Plc AUTL stock halal to invest in?

No, as of February 2026, Autolus Therapeutics Plc stock (AUTL) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Autolus Therapeutics Plc has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Autolus Therapeutics Plc and alternative halal stock options within the Tabadulat app.

How often is Autolus Therapeutics Plc AUTL reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Autolus Therapeutics Plc AUTL monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Autolus Therapeutics Plc AUTL pass the AAOIFI Non Permissible Income criteria?

No, as of February 2026, Autolus Therapeutics Plc stock (AUTL) does not pass the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does Autolus Therapeutics Plc AUTL pass the AAOIFI Interest Bearing Investments criteria?

No, as of February 2026, Autolus Therapeutics Plc stock (AUTL) does not pass the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments have exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

No, as of February 2026, Autolus Therapeutics Plc stock (AUTL) does not pass the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

Autolus Therapeutics Plc

NASDAQ

Shariah-Compliant

Not Shariah

AUTL

About

Autolus Therapeutics Plc

AUTL

Autolus Therapeutics Plc ADR represents shares in Autolus Therapeutics Plc, a biopharmaceutical company specializing in the development of advanced cellular therapies for cancer treatment. The company's primary focus is on leveraging T-cell programming to create targeted treatments aimed at hematological and solid tumor cancers. Notably, Autolus Therapeutics operates within the innovative biotechnology sector, conducting research and development to address unmet medical needs through cutting-edge science and technology. ADRs provide an accessible way for investors to hold shares in a non-US company while supporting its strategic mission to revolutionize cancer therapy. The role of Autolus Therapeutics in the market underscores the growing significance of biopharmaceutical innovations in improving patient outcomes and the broader healthcare landscape.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

647

Website:

https://www.autolus.com

AUTL

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Autolus Therapeutics Plc

About

Autolus Therapeutics Plc

AUTL

Frequently asked questions

Is Autolus Therapeutics Plc AUTL stock halal to invest in?

How often is Autolus Therapeutics Plc AUTL reviewed for Shariah compliance?

Does Autolus Therapeutics Plc AUTL pass the AAOIFI Non Permissible Income criteria?

Does Autolus Therapeutics Plc AUTL pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Autolus Therapeutics Plc AUTL stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.